Patents Examined by Natasha N Patel
-
Patent number: 7512438Abstract: A “tracker system” that includes electrical leads which are part of an implanted cardiotracker plus external equipment that includes external alarm and a physician's programmer. The tracker system is designed to monitor the degradation of a patient's cardiovascular condition from one or more causes, These causes include the rejection of a transplanted heart and/or the progression of a stenosis in a coronary artery. As one or more stenoses in a coronary artery become progressively more narrow thereby causing reduced blood flow to the heart muscle coronary circulation, the tracker system can alert the patient by either or both internal and/or external alarm to take the appropriate medical action. The physician's programmer can be used to display histograms of key heart signal parameters that are indicative of the patient's cardiovascular condition.Type: GrantFiled: September 28, 2004Date of Patent: March 31, 2009Assignee: Angel Medical Systems, Inc.Inventors: David R. Fischell, Robert E. Fischell, Jonathan Harwood, Steven R. Johnson
-
Patent number: 7509159Abstract: Method and apparatus for detecting cardiac repolarization abnormality using at least one electrocardiogram signal. The at least one electrocardiogram signal can be obtained from any number of continuous or non-continuous windows. The method can include deriving a total quantity of representative beats of the at least one electrocardiogram signal. At least one morphology shape descriptor can be used to determine a total quantity of values representing the total quantity of representative beats. Data corresponding to at least some of the total quantity of values can be used to assess cardiac repolarization abnormality.Type: GrantFiled: April 15, 2004Date of Patent: March 24, 2009Assignee: GE Medical Systems Information Technologies, Inc.Inventors: Joel Q. Xue, G. Ian Rowlandson, David Albert
-
Patent number: 7509174Abstract: A device, system and method for diagnosing and treating gastric disorders is provided. A functional device resides within the patient's stomach and is secured to the stomach wall by an attachment device. The functional device may be a sensor for sensing various parameters of the stomach or stomach environment, or may be a therapeutic delivery device. The functional device in one embodiment provides a device, system and method for gastric electrical stimulation where stimulating electrodes are secured to the wall of the stomach by the attachment device or otherwise. A preferred device includes: at least one stimulating electrode in electrical contact with the stomach wall; an electronics unit containing the electronic circuitry of the device; and an attachment mechanism for attaching the device to the stomach wall. The functional devices may be programmed to respond to sensed information or signals.Type: GrantFiled: November 14, 2002Date of Patent: March 24, 2009Assignee: IntraPace, Inc.Inventors: Mir A. Imran, Olivier K. Colliou, Ted W. Layman, Deepak R. Gandhi, Sharon L. Lake
-
Patent number: 7499750Abstract: Implementing a subcutaneous medical electrode system involves positioning a number of electrode subsystems in relation to a heart so that noise cancellation provides an improved signal to noise ratio of the cardiac signal and/or to provide one electrode arrangement preferential for cardiac signals and another arrangement preferential for noise signals. One of the electrode subsystems so positioned may include one or more can electrodes located on a housing enclosing a medical device. The medical device may be configured to provide therapeutic, diagnostic, or monitoring functions, including, for example, cardiac arrhythmia therapy.Type: GrantFiled: December 17, 2003Date of Patent: March 3, 2009Assignee: Cardiac Pacemakers, Inc.Inventors: Paul Haefner, Darrell Orvin Wagner, Jason Alan Shiroff, Marina Brockway, Apurv Kamath
-
Patent number: 7493169Abstract: A method of automatically adjusting an electrode array to the neural characteristics of an individual patient is disclosed. By recording neural response to a predetermined input stimulus, one can alter that input stimulus to the needs of an individual patient. A minimum input stimulus is applied to a patient, followed by recording neural response in the vicinity of the input stimulus. By alternating stimulation and recording at gradually increasing levels, one can determine the minimum input that creates a neural response, thereby identifying the threshold stimulation level. One can further determine a maximum level by increasing stimulus until a predetermined maximum neural response is obtained.Type: GrantFiled: August 2, 2006Date of Patent: February 17, 2009Assignee: Second Sight Medical Products, Inc.Inventors: Robert Greenberg, Richard Williamson
-
Patent number: 7483751Abstract: The invention is a method of automatically adjusting an electrode array to the neural characteristics of an individual patient. By recording neural response to a predetermined input stimulus, one can alter that input stimulus to the needs of an individual patient. A minimum input stimulus is applied to a patient, followed by recording neural response in the vicinity of the input stimulus. By alternating stimulation and recording at gradually increasing levels, one can determine the minimum input that creates a neural response, thereby identifying the threshold stimulation level. One can further determine a maximum level by increasing stimulus until a predetermined maximum neural response is obtained.Type: GrantFiled: June 8, 2004Date of Patent: January 27, 2009Assignee: Second Sight Medical Products, Inc.Inventors: Robert Greenberg, Richard Williamson
-
Patent number: 7483741Abstract: A device and method is disclosed for improving tachyarrhythmia detection when the ventricles are resynchronized by delivering paces to both ventricles separated by a specified negative offset interval. Timing of escape intervals and tachyarrhythmia detection is based upon senses from one of the ventricles designated as a rate ventricle. Techniques are presented for preventing tachyarrhythmia detection from being compromised when the rate ventricle is paced after the other ventricle.Type: GrantFiled: February 10, 2006Date of Patent: January 27, 2009Assignee: Cardiac Pacemakers, Inc.Inventors: Jeffrey E. Stahmann, Andrew P. Kramer, Julio C. Spinelli
-
Patent number: 7480532Abstract: Systems and methods provide baroreflex activation to treat or reduce pain and/or to cause or enhance sedation or sleep. Methods involve activating the baroreflex system to provide pain reduction, sedation, improved sleep or some combination thereof. Systems include at least one baroreflex activation device, at least one sensor for sensing physiological activity of the patient, and a processor coupled with the baroreflex activation device(s) and the sensor(s) for processing sensed data received from the sensor and for activating the baroreflex activation device. In some embodiments, the system is fully implantable within a patient, such as in an intravascular, extravascular or intramural location.Type: GrantFiled: October 20, 2004Date of Patent: January 20, 2009Assignee: CVRX, Inc.Inventors: Robert S. Kieval, Martin A. Rossing
-
Patent number: 7474920Abstract: A device and method to detect slow ventricular tachycardia, deliver anti-tachycardia pacing therapies, and delay a scheduled shock therapy if the ventricular tachycardia is not terminated or accelerated. Preferably, a shock therapy is delayed after verifying hemodynamic stability based on a hemodynamic sensor. After a shock is delayed, the device operates in a high alert mode for redetecting an accelerated tachycardia. Anti-tachycardia pacing therapies are repeated during the shock delay. A number of conditions can trigger delivery of the delayed shock therapy including a specified period of elapsed time; determination that the patient is likely to be asleep; detection of myocardial ischemia; detection of compromised hemodynamics, or detection of a substantially prone position or sudden change in position.Type: GrantFiled: December 12, 2005Date of Patent: January 6, 2009Assignee: Medtronic, Inc.Inventors: John E. Burnes, Paul J. Degroot
-
Patent number: 7471986Abstract: Systems and methods for automatically powering and communicating with an implantable medical device through an inductive link are disclosed. A preferred embodiment comprises an inductive coil or set of such coils. One coil may be mounted or installed on or near the bed of a patient as a component of a transmission module. Another coil may a component of an implantable medical device. The coils are energized by a resonant circuit to generate an electromagnetic field in the vicinity of the bedside. Without any action on the patient's part, the implantable device receives the inductively transmitted energy to power its immediate operation or recharge its battery, thereby extending its longevity, potentially indefinitely. The inductive link also enables data transfer communication between the transmission module and implantable device.Type: GrantFiled: February 20, 2004Date of Patent: December 30, 2008Assignee: Cardiac Pacemakers, Inc.Inventor: John D. Hatlestad
-
Patent number: 7467012Abstract: Heart rate information is used at least in part to obtain one or more parameters for inducing respiration. In various implementations, respiratory parameters, such as a target breathing rate or a target tidal volume may be delivered by an implantable device to a patient during periods of altered respiration, such as sleep apnea or exercise. A respiratory parameter may also be obtained from a physiological variable, a patient's physical activity level, or metabolic demands.Type: GrantFiled: June 24, 2005Date of Patent: December 16, 2008Assignee: Pacesetter, Inc.Inventors: Euljoon Park, Gene A. Bornzin, Mark W. Kroll
-
Patent number: 7463932Abstract: An epicardial pacing lead including a flexible, elongated lead body. The epicardial pacing lead has a proximal end and a distal end. An electrode is coupled to the lead body near the distal end. A housing is coupled to the lead body proximal to the electrode. A platform is at least partially encompassed by the housing. The platform includes at least four tines. Each tine is adapted for engagement with the epicardium and includes an upper section extending outwardly from the platform and a lower section extending distally at an angle to the upper section.Type: GrantFiled: January 14, 2005Date of Patent: December 9, 2008Assignee: Cardiac Pacemakers, Inc.Inventor: James K. Cawthra, Jr.
-
Patent number: 7460902Abstract: A method and system for monitoring atrial activation in a patient is provided. In the method, a moment of occurrence and a wave form are predicted for a subsequent P wave based on a sequence of P waves already received in ECG signal data obtained from the patient. The process then checks whether the subsequent P wave really occurs in the ECG signal data within a first time window around the predicted moment of occurrence. If this is the case, the process further monitors whether the P wave is followed by a QRS complex in the ECG signal data.Type: GrantFiled: February 2, 2005Date of Patent: December 2, 2008Assignee: The General Electric CompanyInventor: Mikko Kaski
-
Patent number: 7460899Abstract: A wrist-worn or arm band worn heart rate variability monitor is provided. Heart rate variability (“HRV”) refers to the variability of the time interval between heartbeats and is a reflection of an individual's current health status. Over time, an individual may use the results of HRV tests to monitor either improvement or deterioration of specific health issues. Thus, one use of the HRV test is as a medical motivator. When an individual has a poor HRV result, it is an indicator that they should consult their physician and make appropriate changes where applicable to improve their health. If an individual's HRV results deviate significantly from their normal HRV, they may be motivated to consult their physician. In addition, the inventive monitor is capable of monitoring the stages of sleep by changes in the heart rate variability and can record the sleep (or rest) sessions with the resulting data accessible by the user or other interested parties.Type: GrantFiled: February 25, 2005Date of Patent: December 2, 2008Assignee: Quiescent, Inc.Inventor: Adam J. Almen
-
Patent number: 7447551Abstract: A flexible implantable electrical stimulator array is provided, which is associated with a flexible circuit board, biocompatible materials, a cathode electrode array and an anode electrode array. By using the flexible circuit board, the implanting position and implanting way of the present electrical stimulator are more flexible. Hence, the present electrical stimulator is more humanized and more widely used. Besides, by a design of electrode arrays, electrical treatment area is enlarged and electrical treatment efficiency is improved.Type: GrantFiled: June 7, 2005Date of Patent: November 4, 2008Assignee: Industrial Technology Research InstituteInventors: Tsung Ter Kuo, Kuo Hua Tseng, Yu Kon Chou
-
Patent number: 7444185Abstract: An active electrode array provides a programmable number of electrode contacts through which stimulation current may be selectively delivered to surrounding tissue, preferably through the use of appropriate stimulation groups. The active electrode array provides a large number of both medial and lateral contacts, any one of which may be selected to apply a stimulus pulse through active switching elements included within the array. The active switching elements included within the array operate at a very low compliance voltage, thereby reducing power consumption.Type: GrantFiled: September 23, 2005Date of Patent: October 28, 2008Assignee: Advanced Bionics, LLCInventors: Michael A Faltys, Glen A Griffith, William VanBrooks Harrison
-
Patent number: 7433737Abstract: An implantable stimulator that includes a housing, a first plastic component, and a second plastic component, where the first and second plastic components form a polymer-polymer interface. A light absorbing metal layer is disposed over at least a portion of the interface and an electronic subassembly is disposed within the housing. The first and second plastic components can be welded together by irradiating the light absorbing metal layer which converts the light to heat.Type: GrantFiled: May 10, 2005Date of Patent: October 7, 2008Assignee: Boston Scientific Neuromodulation CorporationInventors: Tom Xiaohai He, Matthew Isaac Haller, Meredith Lee Anderson
-
Patent number: 7418298Abstract: The present invention is a myocardial lead attachment system and method for securing a distal end of a lead within the myocardium of a patient's heart. The system includes an anchor, a tether coupled at a distal end to the anchor and a lead body. The lead body has a proximal end, a distal end, and a lumen extending therethrough for receiving the tether. A fixation mechanism is at the distal end of the lead body, and is adapted to collapse to a first configuration during implantation and deploy to a second configuration after implantation.Type: GrantFiled: October 22, 2004Date of Patent: August 26, 2008Assignee: Cardiac Pacemakers, Inc.Inventors: Jason Alan Shiroff, Ronald W. Heil, Jr., Peter T. Kelley, M. Sean Coe, Randy W. Westlund, Donald F. Palme, II, David B. Yingling
-
Patent number: 7400920Abstract: Morphological features within electrical cardiac signals are tracked and changes in features are monitored to detect renal failure. The morphological feature may be an interval between corresponding polarization events such as the interval between QRS-complexes and peaks of corresponding T-waves (QTmax interval); the interval between QRS-complexes and ends of corresponding T-waves (QTend interval); or the interval between P-waves and corresponding QRS-complexes (PR interval). The feature may also be the elevation of a cardiac signal segment between corresponding polarization events, such as QRS-complexes and corresponding T-waves (ST segment); a duration of a polarization event, such as a QRS-complex (QRS width); or an amplitude of a polarization event, such as a T-wave (T-wave amplitude).Type: GrantFiled: August 11, 2005Date of Patent: July 15, 2008Assignee: Pacesetter, Inc.Inventors: Jong Gill, Gene A. Bornzin
-
Patent number: 7389134Abstract: An apparatus for and method of measuring pressure through a septum in a patient's heart is disclosed. A lead inserted into the right side of a heart is routed through the septum to gain access to the left side of the heart. The lead includes an attachment structure that secures the lead to one or both of the septal walls. The attachment structure may include at least one protruding tine, membrane, inflatable balloon, involuted spiral or J-lead that engage one or more sides of the septum. The lead also includes one or more sensors for measuring cardiac pressure on the left side of the heart and, as necessary, the right side of the heart.Type: GrantFiled: February 7, 2005Date of Patent: June 17, 2008Assignee: Pacesetter, Inc.Inventors: Annapurna Karicherla, Kevin L. Morgan, Gene A. Bornzin, Sheldon Williams